Sandbox Reserved 911: Difference between revisions

No edit summary
No edit summary
Line 6: Line 6:
Fatty acid amide hydrolase (FAAH) degrades fatty acid amides (FAAs) to terminate their signaling activity <ref name="1MT5">PMID:12459591</ref>. A serine hydrolase from the [http://en.wikipedia.org/wiki/Amidase Amidase] signature superfamily of enzymes ([http://proteopedia.org/wiki/index.php/Category:Amidase other amidases]), FAAH degrades endocannabinoid signaling lipids, molecules associated with pain relief <ref name="2WAP">PMID:19389627</ref>. Because [http://en.wikipedia.org/wiki/Endocannabinoid_system endocannabinoids] are lipid molecules, they cannot be compartmentalized in vesicles (the degradation method for other neurotransmitters) and must instead be degraded in the bilayer of the cell membrane. FAAH is an [http://stevens.scripps.edu/images/faah_fig2.jpg integral membrane protein] that degrades FAAs as they enter the membrane bilayer, allowing the cell to terminate the activity of signaling molecules that cannot be contained within a vesicle for degredation <ref name="1MT5"/>. Current FAAH research aims to find inhibitors for the enzyme, which would prolong the pain alleviation provided by endocannabinoid molecules <ref name="2WAP"/>.
Fatty acid amide hydrolase (FAAH) degrades fatty acid amides (FAAs) to terminate their signaling activity <ref name="1MT5">PMID:12459591</ref>. A serine hydrolase from the [http://en.wikipedia.org/wiki/Amidase Amidase] signature superfamily of enzymes ([http://proteopedia.org/wiki/index.php/Category:Amidase other amidases]), FAAH degrades endocannabinoid signaling lipids, molecules associated with pain relief <ref name="2WAP">PMID:19389627</ref>. Because [http://en.wikipedia.org/wiki/Endocannabinoid_system endocannabinoids] are lipid molecules, they cannot be compartmentalized in vesicles (the degradation method for other neurotransmitters) and must instead be degraded in the bilayer of the cell membrane. FAAH is an [http://stevens.scripps.edu/images/faah_fig2.jpg integral membrane protein] that degrades FAAs as they enter the membrane bilayer, allowing the cell to terminate the activity of signaling molecules that cannot be contained within a vesicle for degredation <ref name="1MT5"/>. Current FAAH research aims to find inhibitors for the enzyme, which would prolong the pain alleviation provided by endocannabinoid molecules <ref name="2WAP"/>.


[[Image:1MT5.png|400 px|left|thumb|FAAH Monomer Subunit; Enzyme in teal, Ligand in pink. FAAH [http://proteopedia.org/wiki/index.php/1mt5 Crystal Structure.]]]
[[Image:1MT5.png|410 px|left|thumb|FAAH Monomer Subunit; Enzyme in teal, Ligand in pink. FAAH [http://proteopedia.org/wiki/index.php/1mt5 Crystal Structure.]]]


==Hydrolase Information==
==Hydrolase Information==
Crystal structures of FAAH show that the enzyme is a <scene name='57/573125/2vya/9'>homodimer</scene> (monomers in different colors) in solution, with each subunit having a mass of 63 kD <ref name="1MT5">PMID:12459591</ref>. The protein's <scene name='57/573125/2vya/8'>twisted Beta sheet core</scene> of 11 strands is surrounded by 24 alpha helices. The enzyme is embedded in the cell <scene name='57/573125/2vya/5'>membrane</scene> to catch the lipid signaling molecules that can diffuse through membranes; the alpha helices' hydrophobic residues interact with the hydrophobic region of the membrane to anchor the enzyme in the lipid bilayer. The FAAH structure shows an entry channel leading from the lipid bilayer to the enzyme's active site, providing a path for endocannabinoids to enter the hydrolase. This entry channel is amphipathic to accommodate the entire lipid signaling molecule. Hydrophobic amino acid residues interact with the lipid signaling molecules' nonpolar tails, while charged R486 and D403 residues in the entry channel accommodate the polar head groups. In addition, FAAH possesses an [http://lem.ch.unito.it/didattica/infochimica/2008_Cioccolato/immagini/strutturafaah.jpg exit channel] leading from the active site to the cell's cytoplasm, allowing the release of polar compounds released from lipid cleavage and the entry of water molecules necessary for the FAAH mechanism to proceed <ref name="1MT5"/>. This hydrolase has a membrane binding cap, a <scene name='57/573125/2vya/7'>helix-turn-helix motif</scene> consisting of alpha helices 18 and 19. These helices present hydrophobic amino acid residues that help FAAH interact with the hydrophobic region of the lipid bilayer <ref name="1MT5"/>. Different inhibitors have been designed to learn more about species selectivity<ref name="2VYA"/> and binding flexibility <ref>PMID:19722626</ref> in FAAH. For example, the <scene name='57/573125/2vya/3'>PF-750 inhibitor</scene> (red) is the inhibitor used on a humanized rat FAAH protein.  Although PF-750 showed preference for human FAAH, rat FAAH is easier to express; this demonstrates species selectivity of inhibitors <ref name="2VYA"/>.
Crystal structures of FAAH show that the enzyme is a <scene name='57/573125/2vya/9'>homodimer</scene> (monomers in different colors) in solution, with each subunit having a mass of 63 kD <ref name="1MT5">PMID:12459591</ref>. The protein's <scene name='57/573125/2vya/8'>twisted Beta sheet core</scene> of 11 strands is surrounded by 24 alpha helices. The enzyme is embedded in the cell <scene name='57/573125/2vya/5'>membrane</scene> to catch the lipid signaling molecules that can diffuse through membranes; the alpha helices' hydrophobic residues interact with the hydrophobic region of the membrane to anchor the enzyme in the lipid bilayer. The FAAH structure shows an entry channel leading from the lipid bilayer to the enzyme's active site, providing a path for endocannabinoids to enter the hydrolase. This entry channel is amphipathic to accommodate the entire lipid signaling molecule. Hydrophobic amino acid residues interact with the lipid signaling molecules' nonpolar tails, while charged R486 and D403 residues in the entry channel accommodate the polar head groups. In addition, FAAH possesses an [http://lem.ch.unito.it/didattica/infochimica/2008_Cioccolato/immagini/strutturafaah.jpg exit channel] leading from the active site to the cell's cytoplasm, allowing the release of polar compounds released from lipid cleavage and the entry of water molecules necessary for the FAAH mechanism to proceed <ref name="1MT5"/>. This hydrolase has a membrane binding cap, a <scene name='57/573125/2vya/7'>helix-turn-helix motif</scene> consisting of alpha helices 18 and 19. These helices present hydrophobic amino acid residues that help FAAH interact with the hydrophobic region of the lipid bilayer <ref name="1MT5"/>. Different inhibitors have been designed to learn more about species selectivity<ref name="2VYA"/> and binding flexibility <ref>PMID:19722626</ref> in FAAH. For example, the <scene name='57/573125/2vya/3'>PF-750 inhibitor</scene> (red) is the inhibitor used on a humanized rat FAAH protein.  Although PF-750 showed preference for human FAAH, rat FAAH is easier to express; this demonstrates species selectivity of inhibitors <ref name="2VYA"/>.


==Catalytic Triad==
==Catalytic Triad==

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA, R. Jeremy Johnson, Rachel Erkilla, Melissa Jones